Skip to content

Phibro Animal Health PAHC Loans Payable, Noncurrent

Loans Payable, Noncurrent at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$531.72M-0.7%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$838.16M-26.4%
Babcock & Wilcox Enterprises logo
Babcock & Wilcox EnterprisesBW
$56.83M+566%
Floor & Decor logo
Floor & DecorFND
$0-100%
US Physical Therapy logo
US Physical TherapyUSPH
$118.97M-7.7%
Phibro Animal Health logo
Phibro Animal HealthPAHC
$597.69M-3.5%

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.27B+159%
Enterprise value$1.25B+167%
P/E13.4×-2.1×
P/S0.9×+0.4×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Reported directly by Phibro Animal Health in its filing.

Tagged under the XBRL concept us-gaap:LongTermLoansPayable.

The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's loans payable, noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phibro Animal Health's loans payable, noncurrent?
Phibro Animal Health (PAHC) reported loans payable, noncurrent of $597.69M in Q1 2026.
How has Phibro Animal Health's loans payable, noncurrent changed year-over-year?
Phibro Animal Health's loans payable, noncurrent decreased by 3.5% year-over-year, from $619.16M to $597.69M.
What is the long-term trend for Phibro Animal Health's loans payable, noncurrent?
Over 4 years (2021 to 2025), Phibro Animal Health's loans payable, noncurrent has grown at a 20.9% compound annual growth rate (CAGR), from $287.71M to $615.44M.
What does loans payable, noncurrent mean?
This reflects the portion of debt obligations that are scheduled to be repaid beyond the next twelve-month period. It represents the company's long-term financial leverage and the structural commitment of future cash flows to service debt. Analyzing this metric allows investors to evaluate the company's long-term capital structure and its ability to sustain debt levels over an extended horizon.